{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:50:09Z","timestamp":1769201409631,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1208\/s12249-021-02196-3","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T21:02:40Z","timestamp":1643403760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Development and Validation of HPLC Method for Efinaconazole: Application to Human Nail Permeation Studies"],"prefix":"10.1208","volume":"23","author":[{"given":"Praveen","family":"Kolimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Kumar","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Shettar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinath","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Repka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Narasimha","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"issue":"10","key":"2196_CR1","doi-asserted-by":"publisher","first-page":"e00442","DOI":"10.1128\/AAC.00442-19","volume":"63","author":"D Monti","year":"2019","unstructured":"Monti D, Mazzantini D, Tampucci S, Vecchione A, Celandroni F, Burgalassi S, Ghelardi E. Ciclopirox and efinaconazole transungual permeation, antifungal activity, and proficiency to induce resistance in Trichophyton rubrum. Antimicrob Agents Chemother. 2019;63(10):e00442\u201319.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2196_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/14656566.2019.1571039","volume":"20","author":"SR Lipner","year":"2019","unstructured":"Lipner SR. Pharmacotherapy for onychomycosis: new and emerging treatments. Expert Opin Pharmacother. 2019;20(6):725\u201335.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"2196_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14728214.2019.1685493","volume":"24","author":"AK Gupta","year":"2019","unstructured":"Gupta AK, Stec N. Emerging drugs for the treatment of onychomycosis. Expert Opin Emerg Drugs. 2019;24(4):213\u201320.","journal-title":"Expert Opin Emerg Drugs."},{"issue":"2","key":"2196_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clindermatol.2009.12.006","volume":"28","author":"O Welsh","year":"2010","unstructured":"Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis. Clin Dermatol. 2010;28(2):151\u20139.","journal-title":"Clin Dermatol"},{"issue":"6","key":"2196_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1203475417716362","volume":"21","author":"AK Gupta","year":"2017","unstructured":"Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525\u201339.","journal-title":"J Cutan Med Surg"},{"issue":"9","key":"2196_CR6","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/jdv.16394","volume":"34","author":"AK Gupta","year":"2020","unstructured":"Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Piraccini BM. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"2196_CR7","doi-asserted-by":"publisher","first-page":"e1004105","DOI":"10.1371\/journal.ppat.1004105","volume":"10","author":"M Ghannoum","year":"2014","unstructured":"Ghannoum M, Isham N. Fungal nail infections (onychomycosis): a never-ending story? PLoS Pathog. 2014;10(6):e1004105.","journal-title":"PLoS Pathog"},{"issue":"11","key":"2196_CR8","first-page":"762","volume":"88","author":"DP Westerberg","year":"2013","unstructured":"Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician. 2013;88(11):762\u201370.","journal-title":"Am Fam Physician"},{"issue":"7","key":"2196_CR9","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/jps.24459","volume":"104","author":"V Bhatt","year":"2015","unstructured":"Bhatt V, Pillai R. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis. J Pharm Sci. 2015;104(7):2177\u201382.","journal-title":"J Pharm Sci"},{"issue":"4","key":"2196_CR10","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1128\/AAC.02056-12","volume":"57","author":"WJ Jo Siu","year":"2013","unstructured":"Jo Siu WJ, Tatsumi Y, Senda H, Pillai R, Nakamura T, Sone D, Fothergill A. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob Agents Chemother. 2013;57(4):1610\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2196_CR11","first-page":"e13613","volume":"33","author":"AK Gupta","year":"2020","unstructured":"Gupta AK, Venkataraman M, Shear NH, Piguet V. Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis. Dermatol Ther. 2020;33(4):e13613.","journal-title":"Dermatol Ther"},{"key":"2196_CR12","doi-asserted-by":"publisher","first-page":"104753","DOI":"10.1016\/j.microc.2020.104753","volume":"155","author":"A Vikas","year":"2020","unstructured":"Vikas A, Rashmin P, Mrunali P, Sandip M, Kaushik T. RP-HPLC method for quantitative estimation of Efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in presence of its degradation products. Microchem J. 2020;155:104753.","journal-title":"Microchem J"},{"issue":"9","key":"2196_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/sscp.202000019","volume":"3","author":"N Patani","year":"2020","unstructured":"Patani N, Patel M, Patel R. Development and validation of HPLC methodology for quantitative estimation of Efinaconazole in topical pharmaceutical formulation prepared in-house for the treatment of onychomycosis. Sep Sci Plus. 2020;3(9):375\u201383.","journal-title":"Sep Sci Plus"},{"issue":"10","key":"2196_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1039\/C9AY02599E","volume":"12","author":"RB Patel","year":"2020","unstructured":"Patel RB, Patel MR, Patni NR, Agrawal V. Efinaconazole: DoE-supported development and validation of a quantitative HPTLC method and its application for the assay of drugs in solution and microemulsion-based formulations. Anal Methods. 2020;12(10):1380\u20138.","journal-title":"Anal Methods"},{"key":"2196_CR15","unstructured":"U.S. Department of Health and Human Services F and DA. Bioanalytical Method Validation Guidance for Industry. US Dep Heal Hum Serv Food Drug Adm [Internet]. 2018;1\u201341. Available from: https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."},{"key":"2196_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jchromb.2018.01.010","volume":"1076","author":"A Police","year":"2018","unstructured":"Police A, Shankar VK, Murthy SN. RP-HPLC method for simultaneous estimation of vigabatrin, gamma-aminobutyric acid and taurine in biological samples. J Chromatogr B. 2018;1076:44\u201353.","journal-title":"J Chromatogr B"},{"issue":"2","key":"2196_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/bmc.2776","volume":"27","author":"SV Kumar","year":"2013","unstructured":"Kumar SV, Rudresha G, Gurav S, Zainuddin M, Dewang P, Kethiri RR, Rajagopal S, Mullangi R. Validated RP-HPLC\/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats. Biomed Chromatogr. 2013;27(2):203\u20137.","journal-title":"Biomed Chromatogr"},{"key":"2196_CR18","doi-asserted-by":"crossref","unstructured":"Shankar VK, Wang M, Ajjarapu S, Kolimi P, Avula B, Murthy R, Khan I, Murthy SN. Analysis of docosanol using GC\/MS: Method development, validation, and application to ex vivo human skin permeation studies. J Pharm Anal. 2021.","DOI":"10.1016\/j.jpha.2021.08.004"},{"issue":"4","key":"2196_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/pharmaceutics10040273","volume":"10","author":"E Cutr\u00edn-G\u00f3mez","year":"2018","unstructured":"Cutr\u00edn-G\u00f3mez E, Anguiano-Igea S, Delgado-Charro MB, G\u00f3mez-Amoza JL, Otero-Espinar FJ. Effect of penetration enhancers on drug nail permeability from cyclodextrin\/poloxamer-solublepolypseudorotaxane-based nail lacquers. Pharmaceutics. 2018;10(4):273.","journal-title":"Pharmaceutics."},{"issue":"3","key":"2196_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejps.2003.07.001","volume":"20","author":"Y Myoung","year":"2003","unstructured":"Myoung Y, Choi HK. Permeation of ciclopirox across porcine hoof membrane: effect of pressure sensitive adhesives and vehicles. Eur J Pharm Sci. 2003;20(3):319\u201325.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"2196_CR21","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1208\/s12249-017-0711-7","volume":"18","author":"P Thatai","year":"2017","unstructured":"Thatai P, Sapra B. Transungual gel of terbinafine hydrochloride for the management of onychomycosis: formulation, optimization, and evaluation. AAPS PharmSciTech. 2017;18(6):2316\u201328.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2196_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.2042-7158.1983.tb04258.x","volume":"35","author":"KA Walters","year":"1983","unstructured":"Walters KA, Flynn GL, Marvel JR. Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum. J Pharm Pharmacol. 1983;35(1):28\u201333.","journal-title":"J Pharm Pharmacol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02196-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-021-02196-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02196-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T16:37:35Z","timestamp":1647275855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-021-02196-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1208\/s12249-021-02196-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"4 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"63"}}